(Q38542576)

4 September 2017

1 reference

title

The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside (English)

1 reference

4 September 2017

1 reference

5

Cezmi A Akdis

1 reference

4 September 2017

4

Mübeccel Akdis

1 reference

4 September 2017

1

Ioana Agache

1 reference

4 September 2017

2

Kazunari Sugita

1 reference

4 September 2017

3

Hideaki Morita

1 reference

4 September 2017

publication date

1 June 2015

1 reference

Current Allergy and Asthma Reports

4 September 2017

published in

1 reference

4 September 2017

volume

15

1 reference

4 September 2017

issue

6

1 reference

4 September 2017

page(s)

29

1 reference

https://scigraph.springernature.com/pub.10.1007/s11882-015-0529-x

4 September 2017

exact match

0 references

cites work

Therapies for allergic inflammation: refining strategies to induce tolerance

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Introduction to asthma and phenotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

From phenotypes to endotypes to asthma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Untangling asthma phenotypes and endotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Type 2 innate lymphoid cells: new players in asthma and allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Innate and adaptive immune responses in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Innate immunity in the lung regulates the development of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Effects of an anti-TSLP antibody on allergen-induced asthmatic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

A thymic stromal lymphopoietin-responsive dendritic cell subset mediates allergic responses in the upper airway mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Re-defining the unique roles for eosinophils in allergic respiratory inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Comparative Analysis of Human Epidermal and Peripheral Blood γδ T Cell Cytokine Profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Allergen challenge in allergic rhinitis rapidly induces increased peripheral blood type 2 innate lymphoid cells that express CD84

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Prostaglandin D₂ pathway upregulation: relation to asthma severity, control, and TH2 inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Mechanisms of IFN-γ-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Asthmatic granulomatosis: a novel disease with asthmatic and granulomatous features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Interleukin-17 cytokine signalling in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

The broken balance in aspirin hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Leptin is an eosinophil survival factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

TSLP induces mast cell development and aggravates allergic reactions through the activation of MDM2 and STAT6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

T-helper type 2-driven inflammation defines major subphenotypes of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Exhaled nitric oxide in childhood asthma: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Factors contributing to an accelerated decline in pulmonary function in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

High blood eosinophil count is associated with more frequent asthma attacks in asthma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Factors associated with persistent airflow limitation in severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Salivary inflammatory mediator profiling and correlation to clinical disease markers in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Cluster analysis and characterization of response to mepolizumab. A step closer to personalized medicine for patients with severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Predicting steroid responsiveness in patients with asthma using exhaled breath profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Lebrikizumab treatment in adults with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Molecular biology of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Immunological and molecular targets of atopic dermatitis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-015-0529-X

Fluctuation phenotyping based on daily fraction of exhaled nitric oxide values in asthmatic children

21 January 2018

1 reference

12 December 2020

CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation

1 reference

12 December 2020

Predictive value of lung function trend and FeNO for difficult asthma in children

1 reference

12 December 2020

Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system

1 reference

12 December 2020

Increased serum IL-17 is an independent risk factor for severe asthma

1 reference

12 December 2020

Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161

1 reference

12 December 2020

Myeloid dendritic cells type 2 in allergic asthma

1 reference

12 December 2020

TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation

1 reference

12 December 2020

Leptin-mediated cytokine release and migration of eosinophils: implications for immunopathophysiology of allergic inflammation

1 reference

12 December 2020

10.1007/S11882-015-0529-X

Identifiers

DOI

1 reference

Dimensions Publication ID

4 September 2017

1048517175

0 references

1 reference